Griffin Myers sells 50,000 shares of Oak Street Health, Inc. (NYSE:OSH)

Oak Street Health, Inc. (NYSE: OSH – Get a rating) insider Griffin Myers sold 50,000 shares of Oak Street Health in a trade dated Thursday, September 22. The shares were sold at an average price of $26.32, for a total transaction of $1,316,000.00. Following the sale, the insider now owns 4,854,159 shares of the company, valued at $127,761,464.88. The sale was disclosed in a legal filing with the SEC, accessible via this link.

Griffin Myers also recently made the following trade(s):

  • On Thursday, September 8, Griffin Myers sold 50,000 shares of Oak Street Health. The shares were sold at an average price of $27.39, for a total transaction of $1,369,500.00.
  • On Thursday, August 25, Griffin Myers sold 50,000 shares of Oak Street Health. The shares were sold at an average price of $28.95, for a total transaction of $1,447,500.00.
  • On Thursday, August 11, Griffin Myers sold 50,000 shares of Oak Street Health. The shares were sold at an average price of $29.08, for a total transaction of $1,454,000.00.
  • On Thursday, July 28, Griffin Myers sold 200,000 shares of Oak Street Health. The shares were sold at an average price of $28.63, for a total transaction of $5,726,000.00.

Oak Street Health Price Performance

NYSE OSH shares were down $1.47 during Friday trading, hitting $24.75. The company had a trading volume of 2,924,921 shares, compared to its average volume of 2,479,735. Oak Street Health, Inc. has a 52-week low of $13.29 and a 52-week high of 48 $.87. The company’s 50-day moving average price is $27.35 and its 200-day moving average price is $22.97. The company has a debt ratio of 16.10, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market capitalization of $5.97 billion, a PE ratio of -11.13 and a beta of 3.01.

Oak Street Health (NYSE:OSH- Get a rating) last released its quarterly results on Tuesday, August 2. The company reported ($0.66) EPS for the quarter, missing the ($0.49) consensus estimate of ($0.17). Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 27.11%. The company posted revenue of $523.70 million for the quarter, versus analyst estimates of $520.62 million. Analysts expect Oak Street Health, Inc. to post earnings per share of -2.44 for the current year.

Analyst upgrades and downgrades

OHS has been the subject of several analyst reports. SVB Leerink raised its price target on Oak Street Health shares from $23.00 to $32.00 and gave the company a “market performance” rating in a Thursday, Aug. 4, report. UBS Group raised its price target on Oak Street Health shares from $26.00 to $28.00 and gave the company a “neutral” rating in a Wednesday, Aug. 3 report. Barclays raised its price target on Oak Street Health shares from $31.00 to $34.00 and gave the company an “overweight” rating in a Monday, August 8 report. Cowen raised his price target on Oak Street Health shares to $34.00 in a Tuesday, August 9 report. Finally, Morgan Stanley raised its price target on Oak Street Health shares from $19.00 to $30.00 and gave the company an “equal weight” rating in a Wednesday, Aug. 31 report. One research analyst has rated the stock with a sell rating, six have issued a hold rating and eight have assigned the company a buy rating. According to MarketBeat, Oak Street Health has a consensus rating of “Hold” and a consensus target price of $32.75.

Institutional investors weigh in on Oak Street Health

Several institutional investors have recently changed their stake in the company. Victory Capital Management Inc. increased its position in Oak Street Health shares by 7.0% during the first quarter. Victory Capital Management Inc. now owns 14,994 shares of the company worth $271,000 after purchasing an additional 975 shares during the period. Utah Retirement Systems increased its holdings in Oak Street Health by 5.4% in the second quarter. Utah Retirement Systems now owns 19,400 shares of the company valued at $319,000 after purchasing an additional 1,000 shares during the period. Benjamin Edwards Inc. increased its holdings in Oak Street Health by 9,016.7% in the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company valued at $29,000 after purchasing an additional 1,082 shares during the period. Bell Bank increased its holdings in Oak Street Health by 5.9% in the second quarter. Bell Bank now owns 19,905 shares of the company valued at $327,000 after purchasing an additional 1,112 shares during the period. Finally, Nissay Asset Management Corp Japan ADV increased its holdings in Oak Street Health by 11.8% during the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 11,943 shares of the company valued at $396,000 after purchasing an additional 1,265 shares during the period. Institutional investors and hedge funds hold 91.33% of the company’s shares.

Company Profile Oak Street Health

(Get a rating)

Oak Street Health, Inc, together with its subsidiaries, provides patient health services in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio and Texas.

See also

Insider buying and selling by quarter for Oak Street Health (NYSE:OSH)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to contact@marketbeat.com.

Before you consider Oak Street Health, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Oak Street Health wasn’t on the list.

Although Oak Street Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

Comments are closed.